Tatva Chintan Pharma Chem Ltd IPO - July 16, 2021
All you need to know about the Tatva Chintan Pharma Chem Ltd
IPO before investing.
Company Background
Tatva Chintan Pharma Chem is special in chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents, phase transfer catalysts, electrolyte salts for super capacitor batteries and pharmaceuticals and agrochemical intermediates and other specialty chemicals. The company is the largest and only commercial manufacturer of SDAs for zeolites in India. The company enjoys the second largest position globally. The company is promoted by Chintan Shah, Ajay Patel and Shekhar Somani, who each have over 24 years in the specialty chemicals manufacturing industry and have established strong business relationships with domestic as well as overseas customers. In addition, they are led by a well – qualified and experienced management team, which we believe has demonstrated its ability to manage and grow their operations and has substantial experience in the sectors in which they operate. The company believe that the knowledge and experience of their management team provides them with a significant competitive advantage as they seek to grow their business.
Business Information
The Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. As a manufacturer of specialty chemicals, the company focus on application of their products which form a key ingredient to the customers’ manufacturing and industrial processes. For instance, the SDA and PTC products have various applications in green chemistry, which is pertinent considering the growing focus on green and sustainable technologies.
Facts about the company
The company continuously strive to improve their processes and infrastructure to help reduce the impact on the environment and have accordingly, undertaken various ‘green’ chemistry processes such as electrolysis.
Considering the wide application of products, the company serve customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries.
Apart from their customers in India, the company also export their products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK.
Points to note before investing in Tavtva Chintan Pharma Chem Ltd IPO
Diversified product portfolio
The company is a leading manufacturer of structure directing agents and phase transfer catalyst
Global market presence with customer base across industries.
Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
Experienced promoters and managers team.
Strong financial performance track record.
IPO Opening Date
| July 16, 2021
|
IPO Closing Date
| July 20, 2021
|
Issue Type
| Book Built Issue IPO
|
Face Value
| ₹10 per equity share
|
IPO Price
| ₹1073 to ₹1083 per equity share
|
Market Lot
| 13 Shares
|
Min Order Quantity
| 13 Shares
|
Listing At
| BSE, NSE
|
Allotment , Listing and Refunds details
Basis of Allotment Date
| July 26, 2021
|
Initiation of Refunds
| July 27, 2021
|
Credit of Shares to Demat Account
| July 28, 2021
|
IPO Listing Date
| July 29, 2021
|
We hope this information was helpful. For more details, you can post your queries below and we will be happy to share it with you.
Thank You!